Search fresh public links, source activity, and ready-to-use post angles for Glp1S.
Fresh curated links around GLP1s are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
A once-daily GLP-1 receptor agonist decreased events of level 2 and level 3 hypoglycemia for adults after Roux-en-Y gastric bypass, according to topline results from a phase 3 tria...
Based on Danish data, the study found those on GLP-1s had 17% less long-term absences.
Based on Danish data, the study found those on GLP-1s had 17% less long-term absences.
Based on Danish data, the study found those on GLP-1s had 17% less long-term absences.
The higher-dosage GLP-1 agonists largely engendered greater cardiometabolic improvements.
The benefits of GLP-1s keep adding up.
The benefits of GLP-1s keep adding up.
The higher-dosage GLP-1 agonists largely engendered greater cardiometabolic improvements.
GLP-1 drugs, originally developed to treat diabetes and now widely used for obesity, are reshaping healthcare in the US.
New research examines the emerging benefits and unanswered questions surrounding this rapidly expanding class of medications. Millions of people are now using GLP-1 receptor agonis...
For a lot of older adults, especially those carrying real cardiovascular or metabolic risk, GLP-1s may offer benefits beyond the number on the scale when under a doctor's supervisi...
A new study establishes that GLP-1 receptor agonists significantly reduce core behavioral markers of Binge Eating Disorder, including active binge episodes, loss-of-control eating,...
PARK CITY, Utah — When used for weight loss, previously published literature has shown GLP-1s may lead to bone resorption and muscle loss. However, a presenter here said the additi...
GLP-1s are disrupting a healthcare system built around treating obesity-related complications, forcing providers, insurers and investors to rethink where future revenue and growth...
Are GLP-1s for life? What we know about getting older on weight-loss drugs
Finally, Some Evidence Employers Can Use to Justify Covering GLP-1s Anonymous (not verified) Thu, 08/27/2026 - 09:40 pharmagather item url Finally, Some Ev...
There is little debate over which Wall Street profit story is the biggest of the moment: artificial intelligence. For second-biggest, consider the case for GLP-1 drugs.
From unexpected babies to "Ozempic teeth," the ultra-popular class of GLP-1 medications are turning out to have a few unanticipated side effects.
From unexpected babies to "Ozempic teeth," the ultra-popular class of GLP-1 medications are turning out to have a few unanticipated side effects. Emerging research shows the drugs,...
From unexpected babies to "Ozempic teeth," the ultra-popular class of GLP-1 medications are turning out to have a few unanticipated side effects. Emerging research shows the drugs,...
What the evidence says about their growing list of established and emerging uses The post GLP-1 medications beyond weight loss: how far could their benefits extend? appeared first...
From unexpected babies to "Ozempic teeth," the ultra-popular class of GLP-1 medications are turning out to have a few unanticipated side effects. Emerging research shows the drugs,...
Sales of Mounjaro, Eli Lilly’s diabetes drug, rose 91 per cent in the second quarter of the year to US$9.94 billion, well above analysts' expectations.
Unfortunately, testing hunger neurons in a living person isn't possible, but the study's authors hope their data can guide researchers toward new weight loss treatments.
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.